First Time Loading...

Interpace Biosciences Inc
OTC:IDXG

Watchlist Manager
Interpace Biosciences Inc Logo
Interpace Biosciences Inc
OTC:IDXG
Watchlist
Price: 1.42 USD -3.4% Market Closed
Updated: Jun 11, 2024

Interpace Biosciences Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Interpace Biosciences Inc
Total Equity Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Interpace Biosciences Inc
OTC:IDXG
Total Equity
-$14.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
DaVita Inc
NYSE:DVA
Total Equity
$926m
CAGR 3-Years
-9%
CAGR 5-Years
-25%
CAGR 10-Years
-15%
Quest Diagnostics Inc
NYSE:DGX
Total Equity
$6.4B
CAGR 3-Years
-2%
CAGR 5-Years
4%
CAGR 10-Years
5%
CVS Health Corp
NYSE:CVS
Total Equity
$74B
CAGR 3-Years
1%
CAGR 5-Years
4%
CAGR 10-Years
7%
Cigna Corp
NYSE:CI
Total Equity
$41.2B
CAGR 3-Years
-5%
CAGR 5-Years
-1%
CAGR 10-Years
15%
Laboratory Corporation of America Holdings
NYSE:LH
Total Equity
$8B
CAGR 3-Years
-7%
CAGR 5-Years
2%
CAGR 10-Years
12%

See Also

What is Interpace Biosciences Inc's Total Equity?
Total Equity
-14.6m USD

Based on the financial report for Mar 31, 2024, Interpace Biosciences Inc's Total Equity amounts to -14.6m USD.

What is Interpace Biosciences Inc's Total Equity growth rate?
Total Equity CAGR 1Y
9%

Over the last year, the Total Equity growth was 9%.